Navigation Links
Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants.

The new study, published in the March 22 issue of The Journal of Neuroscience, may have implications for developing new therapies for metachromatic leukodystrophy, or MLD, a fatal, relatively rare inherited disorder that in humans usually begins early in life. In the disease, the fatty substance sulfatide accumulates in the brain due to the lack of an enzyme and causes loss of the white matter or myelin protecting nerve fibers. Without myelin, nerves cannot conduct impulses to and from other areas of the body, resulting in symptoms including convulsions, seizures, personality changes, spasticity, progressive dementia, motor disturbances progressing to paralysis, and blindness. There is no cure; the only current treatment is a bone marrow transplant.

Ernesto Bongarzone, PhD, and his colleagues at the San Raffaele Scientific Institute in Milan, Italy, transplanted cells that produce myelin into the brains of newborn MLD mice. The researchers found that the transplanted myelin-producing cells survived in the mice brains and successfully moved to regions of the brain where they could aid in producing myelin. The transplanted cells also helped lead to production of healthy myelin and improved motor coordination.

"There is much excitement in the field of cell-based therapy and this study is a clear indication of its potential," says Mahendra Rao, MD, PhD, at Johns Hopkins School of Medicine and the Invitrogen Corporation. "This carefully conducted study suggests that a different cell type, such as myelin-producing cells, may be better than others when used for therapy."

"These results contribute to a growing field of intense research where the use of brain-derived cells, including myelin-producing cells and neural stem cells, may be envisioned as di rect cell therapies to target specific neurological diseases," says Bongarzone.


'"/>

Source:Society for Neuroscience


Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... DALLAS (PRWEB) , ... September 06, 2018 , ... ... with Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes ... advancements directly related to the spine that result from it. The deal will ...
(Date:8/31/2018)... ... August 30, 2018 , ... Vinita Madill, ... Novak, infrared materials engineer, LightPath Technologies. In the future, these names may be ... her 100th birthday. Today, they are among 26 scientists whose work and words ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... chromosomal abnormalities using morphological assessment through artificial intelligence , A recent, international ... Whisperer suggests that artificial intelligence (AI) models, applied to 2D images ...
Breaking Biology News(10 mins):
(Date:9/22/2018)... HAYWARD, Calif. and WESTMINSTER, Colo. (PRWEB) , ... ... ... Predicine and Flagship Biosciences are excited to announce a strategic venture. ... intelligence-enabled cTA® digital pathology platform provides complimentary and comprehensive biomarker profiling to ...
(Date:9/15/2018)... ... ... Nationally recognized public accounting and consulting firm Cherry Bekaert LLP (“the ... practice, on her appointment to Launch Tennessee’s Board of Directors. , Patrick ... the Firm’s Nashville practice in December 2017 . In this role, she oversees the ...
(Date:9/12/2018)... (PRWEB) , ... September 11, 2018 , ... ... proud to add flat sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions ... membranes manufactured by FTS H2O are constructed from cellulose triacetate (CTA) material. The ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... is releasing the agenda for its upcoming user conference. , This year ... the latest challenges, opportunities, and approaches to regulatory compliance and quality management. , ...
Breaking Biology Technology: